Friday 6 November 2026 Export WORX’s income statement to Excel — free account

SCWorx Corp.

WORX Healthcare Health Information Services

SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024.

Revenue: +3.43%
EPS: +98.4%
Free cash flow: +88.0%

Quarter to June 2026, against a year earlier

1.32 0.10 −7.04%

Follow WORX

Alert me

Market cap: $2.0M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 4/9
Altman Z: −5.04
Beneish M: −4.31
Dividend safety: n/a

Overview

Insider Decisions last twelve months

Trades a month
	Jan 26			Apr 26			Jul 26			Oct 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Size

Market Cap 1.97

Revenue ttm 2.93

Net income ttm (2.36)

Free cash flow ttm (0.90)

Net debt Q (1.26)

Valuation

P/E 0.00

Forward P/E (2.57)

Price / sales 0.04

Forward P/S Powerpack

Price / FCF 0.00

Price / book 0.02

Financial health

Current ratio Q 2.19

Debt / equity Q 0.00

Interest coverage Q (3.57)

Growth

Revenue growth Q +3.43%

Operating income growth Q +58.77%

EPS, this year +21.60%

EPS, next year A —

Revenue, next year A −12.79%

EPS, past 5 yrs —

EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.18%

10-year low 10-year high

P/B against its own 10 years 0.17%

10-year low 10-year high

Dividends

Yield: —
Annual rate: —
Payout ratio: —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	0	0	2	1
Receivables	0	0	0	0
Inventory	—	—	—	—
Other	—	—	—	—
	0	1	2	2

	2023	2024	2025	Q'26
Payables	2	1	1	1
ST’ Debt	—	—	—	—
Other	0	0	—	—
	2	2	1	1

Compound Annual Growth %

	10y	5y	3y
Sales	—	(11.21%)	(10.68%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	4.52%	1.82%

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.92)	(1.35)	—	—	—
’25	(44.53)	(82.79)	(27.00)	(9.30)	(109.79)
’24	(25.20)	(46.79)	(48.59)	(20.33)	(140.39)
’23	(80.95)	(26.98)	(137.12)	(443.53)	(694.73)
’22	(161.90)	(134.92)	(5.96)	(53.97)	(404.76)
’21	(188.89)	(323.81)	(242.85)	(202.71)	(979.53)
’20	(404.76)	(1.11k)	(770.83)	90.92	(2.21k)

Fiscal quarters ending in the months shown.

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1	1	—	—	—
’25	1	1	1	1	3
’24	1	1	1	1	3
’23	1	1	1	1	4
’22	1	1	1	1	4
’21	1	1	1	1	5
’20	1	1	1	1	5

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jun	Sep	Dec	Year
’26	0	—	—	—
’25	(1)	0	0	(2)
’24	0	(1)	0	(1)
’23	0	0	0	(1)
’22	0	0	0	(1)
’21	0	0	0	(1)
’20	(1)	0	0	(1)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jun	Sep	Dec	Year
’26	0	—	—	—
’25	(1)	0	0	(2)
’24	0	(1)	0	(1)
’23	0	0	0	(1)
’22	0	0	0	(1)
’21	0	0	0	(1)
’20	(1)	0	0	(1)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM Jun ’26	Trend	10 yrs	2026e	2027e	2028e	Next 3/yr
													Ten-year view		Analyst estimates Powerpack
Income, $m
Income, $m	Revenue	1	0	3	6	5	5	4	4	3	3	3		+19.2%	—	—	—	—
	Gross margin, %	35.00	100.00	14.83	21.02	32.57	39.94	35.01	33.35	24.95	31.96	44.67		(3.0) pt	Powerpack SCWorx Corp.’s next three years, line by line See the consensus for every other line: earnings, margins, cash flow, valuation and returns. Unlock estimates Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time. Also in Powerpack: every quarter, Excel exports, API & MCP access. Compare plans
	EBT	(5)	(3)	0	(11)	(7)	(4)	(2)	(4)	(1)	(4)	(2)		(1.1%)
	EBT margin, %	(831.08)	(1,436.84)	(11.12)	(203.90)	(142.00)	(82.34)	(45.75)	(104.63)	(38.01)	(154.44)	(80.55)		+676.6 pt
	Net income	(4)	(12)	0	(11)	(7)	(4)	(2)	(4)	(1)	(4)	(2)		+0.7%
Per share, $
Per share, $	Revenue	5,914.00	1,103.50	2,012.88	2,412.22	1,533.26	1,187.82	917.77	667.53	369.09	71.23	32.76		(38.8%)
	Earnings	(38,649.65)	(57,448.54)	(229.45)	(4,884.07)	(2,222.87)	(984.02)	(404.76)	(694.73)	(140.39)	(109.79)	(39.57)		(47.9%)
	Cash flow	(20,181.00)	(29,141.50)	(141.82)	(2,039.70)	(282.09)	(274.33)	(122.73)	(141.44)	(133.86)	(38.21)	(8.35)		(50.2%)
	Capex	(1,116.00)	0.00	0.00	(48.57)	0.00	0.00	0.00	0.00	0.00	(0.76)	(1.77)		(55.5%)
	Free cash flow	(21,297.00)	(29,141.50)	(141.82)	(2,088.26)	(282.09)	(274.33)	(122.73)	(141.44)	(133.86)	(38.97)	(10.12)		(50.4%)
	Book value	137,118.00	40,672.50	(136.41)	3,011.13	1,686.47	1,642.33	1,540.11	676.04	554.27	177.04	77.63		(52.2%)
	Shares, m	0	0	0	0	0	0	0	0	0	0	0		+94.8%
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.0
	P/S	0.00	58.11	4.13	3.21	2.38	2.93	1.14	0.49	0.82	0.47	0.04		7.4
	P/B	1.40	1.58	0.00	2.57	2.16	2.12	0.68	0.49	0.55	0.19	0.02		1.2
	EV/Sales	0.00	58.45	4.16	3.17	2.41	3.07	1.19	0.56	0.89	(0.01)	(0.29)		7.4
	EV/FCF	(7.21)	(2.21)	(59.08)	(3.67)	(12.05)	(12.31)	(7.66)	(2.41)	(2.26)	0.02	0.94		(10.9)
Cash, $m
Cash, $m	Operating cash flow	(2)	(6)	0	(5)	(1)	(1)	(1)	(1)	(1)	(2)	(1)		(2.9%)
	Capex	0	—	—	0	—	—	—	—	—	0	0		(13.4%)
	Free cash flow	(2)	(6)	0	(5)	(1)	(1)	(1)	(1)	(1)	(2)	(1)		(3.3%)
Balance, $m
Balance, $m	Working capital	5	(1)	0	(2)	(2)	(2)	(1)	(2)	(1)	1	1		(13.1%)
	Net debt	(5)	0	1	0	0	0	0	0	0	(2)	(1)		(11.0%)
	Shareholders’ equity	14	8	0	7	6	6	7	4	4	7	7		(7.0%)
Returns, %
Returns, %	ROA	(59.33)	(100.87)	(5.95)	(173.71)	(71.80)	(38.63)	(20.11)	(51.29)	(18.00)	(62.41)	(32.83)		(3.1) pt
	ROIC	(33.98)	(24.49)	(7.77)	(115.51)	(66.85)	(35.23)	(19.88)	(23.54)	(17.88)	(10.88)	(6.48)		+23.1 pt
	ROE	(62.40)	(109.66)	(9.63)	(338.03)	(116.95)	(62.85)	(28.03)	(74.90)	(27.24)	(76.35)	(38.06)		(13.9) pt
People
People	Employees	36	34	4	4	9	10	9	7	7	9	—		(14.3%)
	Revenue/emp, $m	0.02	0.01	0.86	1.39	0.58	0.46	0.45	0.54	0.43	0.32	—		+39.1%

Negative figures in brackets.

estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HLTHQ Cue Health Inc.	$6.9M	— (loss-making)	— (loss-making)	−87.19% (below 0%: shrinking)	n/m	+50.55% (above 0%: growing)	(90.14%)	(792.13%)	Compare
ACON Aclarion, Inc.	$4.5M	— (loss-making)	— (loss-making)	+78.48% (above 0%: growing)	n/m	−74.22% (below 0%: shrinking)	43.86%	(8,164.70%)	Compare
MGRX Mangoceuticals, Inc.	$4.3M	— (loss-making)	—	−59.07% (below 0%: shrinking)	n/m	+79.27% (above 0%: growing)	64.24%	(1,501.45%)	Compare
ZCMD Zhongchao Inc.	$4.3M	— (loss-making)	—	+20.44% (above 0%: growing)	−550.00% (below 0%: shrinking)	+191.85% (above 0%: growing)	41.67%	0.00%	Compare
HCTI Healthcare Triangle, Inc.	$3.2M	0.0×	— (loss-making)	+158.38% (above 0%: growing)	n/m	+67.48% (above 0%: growing)	22.48%	(44.28%)	Compare
VSEE VSee Health, Inc.	$2.8M	— (loss-making)	— (loss-making)	−53.93% (below 0%: shrinking)	n/m	−257.62% (below 0%: shrinking)	13.20%	(172.69%)	Compare
WORX SCWorx Corp.	$2.0M	— (loss-making)	— (loss-making)	+3.43% (above 0%: growing)	n/m	+87.99% (above 0%: growing)	46.80%	(17.14%)
MSPR MSP Recovery, Inc.	$1.5M	— (loss-making)	—	−94.60% (below 0%: shrinking)	n/m	+60.88% (above 0%: growing)	(26.77%)	(62,501.52%)	Compare
MNDR Mobile-health Network Solutions	$1.1M	—	—	—	—	—	—	—	Compare
Median of peers	$3.7M	—	—	−53.93%	—	+60.88%	22.48%	(792.13%)

All 44 Health Information Services stocks →

SCWorx Corp. (WORX) Latest News

19 Oct

Impact 3 · 10:10 AM · GlobeNewswire

SCWorx Announces New Agreement with Healthcare System

7 Oct

Impact 4 · 2:23 PM · GlobeNewswire

SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy

6 Oct

Impact 4 · 10:15 AM · GlobeNewswire

SCWorx Renews Agreement with Existing Healthcare Partner for Additional Three Years and 113% Increase in Contract Value

Impact 3 · 2:17 PM · GlobeNewswire

SCWorx Announces Nasdaq Trading to Resume October 7, 2026

5 Oct

Impact 4 · 1:07 PM · GlobeNewswire

SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market

17 Sep

Impact 3 · 9:07 AM

SCWorx Announces Equity Financing with Institutional Investors

6 Aug

Impact 3 · 11:03 AM

SCWorx Announces New Two-Year Agreement with One of Massachusetts’ Largest Integrated Delivery Networks

29 Jul

Impact 3 · 10:15 AM

SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market

8 Jul

Impact 3 · 10:00 AM

SCWORX ANNOUNCES DEPLOYMENT OF AI-ASSISTED DATA MANAGEMENT MODEL FOR HEALTHCARE SUPPLY CHAIN DATA ATTRIBUTES

23 Jun

Impact 4 · 3:41 PM · GlobeNewswire

SCWorx Receives Nasdaq Hearings Panel Decision Granting the Company’s Request to Continue its Listing on the Nasdaq Stock Market, Subject to Compliance Conditions

4 Mar

Impact 4 · 10:11 AM · GlobeNewswire

SCWorx Announces New SaaS and Data Management Customer Supporting a Prominent Southeastern Healthcare Provider’s Workday Platform

12 Feb

Impact 3 · 10:30 AM

BC-Most Active Stocks

23 Jan

Impact 3 · 10:30 AM · Associated Press Finance

BC-Most Active Stocks

17 Dec

Impact 3 · 10:10 AM · GlobeNewswire

SCWorx Announces New Academic Hospital Customer

15 Dec

Impact 4 · 9:45 AM · GlobeNewswireGuruFocus.comHospital ManagementMT NewswiresMedical Device NetworkMT NewswiresMT Newswires

SCWorx Continues to Expand Healthcare Data Management Network with New Partnership

14 Oct

Impact 3 · 10:15 AM · GlobeNewswireMT NewswiresMT NewswiresMT NewswiresMT NewswiresMT NewswiresTipRanksMT Newswires

SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

3 Sep

Impact 4 · 11:44 AM · GlobeNewswire

SCWorx Corp. Appoints New Chief Technology Officer to Accelerate Innovation in Healthcare Data Solutions

26 Aug

Impact 4 · 10:55 AM · GlobeNewswire

SCWorx Expands Healthcare Data Management Network with New Collaboration

Impact 3 · 10:30 AM · Associated Press Finance

BC-Most Active Stocks

13 Aug

Impact 4 · 9:35 AM · GlobeNewswire

Florida Hospital Selects SCWorx for Data Management for Workday Implementation

10 Jul

Impact 4 · 3:57 PM · Reuters

Former CEO of SCWorx Corp convicted of securities fraud over COVID tests

Impact 4 · 3:33 PM · The Wall Street Journal

Jury Finds Healthcare Company CEO Misled Investors Over Covid-19 Tests

21 May

Impact 3 · 2:37 PM · GlobeNewswire

SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024

23 Oct

Impact 4 · 9:30 AM · GlobeNewswire

SCWorx Signs Letter of Intent to Acquire an Environmental Services Company

10 Oct

Impact 3 · 12:21 PM · GlobeNewswire

SCWorx Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting

SCWorx Corp.

Insider Decisions last twelve months

Capital & Financial Ratios $m

Valuation vs history

Dividends

Assets vs Liabilities $m

Compound Annual Growth %

EPS $

Revenue $m

Operating Cash Flow $m

Free Cash Flow $m

Target Price Range

Recommendation Rating

Ten years at a glance Fiscal years to December

SCWorx Corp. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

SCWorx Corp. (WORX) Latest News

19 Oct

7 Oct

6 Oct

5 Oct

17 Sep

6 Aug

29 Jul

8 Jul

23 Jun

4 Mar

12 Feb

23 Jan

17 Dec

15 Dec

14 Oct

3 Sep

26 Aug

13 Aug

10 Jul

21 May

23 Oct

10 Oct

Insider Decisions last twelve months

Capital & Financial Ratios $m

Valuation vs history

Dividends

Assets vs Liabilities $m

Compound Annual Growth %

EPS $

Revenue $m

Operating Cash Flow $m

Free Cash Flow $m

Target Price Range

Recommendation Rating

Ten years at a glance Fiscal years to December

SCWorx Corp. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

SCWorx Corp. (WORX) Latest News

19 Oct

7 Oct

6 Oct

5 Oct

17 Sep

6 Aug

29 Jul

8 Jul

23 Jun

4 Mar

12 Feb

23 Jan

17 Dec

15 Dec

14 Oct

3 Sep

26 Aug

13 Aug

10 Jul

21 May

23 Oct

10 Oct

Stockrow Weekly